Trials / Terminated
TerminatedNCT05219604
Central Nervous System Effects Following Infusion of Diphenhydramine Using Pharmacokinetic and Pharmacodynamic Modeling
The Magnitude and Duration of the Central Nervous System Effects Following Intravenous Infusion of Diphenhydramine Using Pharmacokinetic and Pharmacodynamic Modeling
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 3 (actual)
- Sponsor
- Dent Neuroscience Research Center · Academic / Other
- Sex
- All
- Age
- 35 Years
- Healthy volunteers
- Accepted
Summary
This study seeks to explore the magnitude and duration of central nervous system effects and pharmacokinetics after intravenous infusion of diphenhydramine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DiphenhydrAMINE Injectable Solution | Intravenous infusion of diphenhydramine 50 mg. |
Timeline
- Start date
- 2022-03-15
- Primary completion
- 2022-10-04
- Completion
- 2022-10-04
- First posted
- 2022-02-02
- Last updated
- 2026-01-22
- Results posted
- 2026-01-22
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05219604. Inclusion in this directory is not an endorsement.